Natriuretic peptides and heart failure in the patient with chronic kidney disease: A review of current evidence

Postgraduate Medical Journal

Volumn 85, Issue 1004, 2009, Pages 299-302

  Dhar, S ^a   Pressman, G S ^b   Subramanian, S ^b   Kaul, S ^c   Gollamudi, S ^c   Bloom, E J ^b   Figueredo, V M ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; NESIRITIDE;

CHRONIC KIDNEY DISEASE; DIAGNOSTIC TEST; DISEASE MARKER; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; PROGNOSIS; REVIEW; URINARY EXCRETION;

BIOLOGICAL MARKERS; CHRONIC DISEASE; CYCLIC GMP; HEART FAILURE; HUMANS; KIDNEY DISEASES; NATRIURETIC PEPTIDES; RENAL DIALYSIS;

EID: 67649703545     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2008.073734     Document Type: Review

References (48)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047 (Pubitemid 350074801)
2. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 1997;47:287-296
3. Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81. (Pubitemid 18083551)
4. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991;17:1152-1155
5. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1558-1564
6. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993;132:1961-1970 (Pubitemid 23133241)
7. Onuoha GN, Nicholls DP, Patterson A, et al. Neuropeptide secretion in exercise. Neuropeptides 1998;32:319-325 (Pubitemid 28439218)
8. Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 1998;274:H1684-9. (Pubitemid 128733282)
9. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-356 (Pubitemid 36724374)
10. Ogawa Y, Nakao K, Mukoyama M, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991;69:491-500.
11. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-982 (Pubitemid 34994995)
12. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-2368 (Pubitemid 50011582)
13. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-328 (Pubitemid 28366422)
14. Charles CJ, Espiner EA, Nicholls MG, et al. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol 1996;271:R373-80. (Pubitemid 126757460)
15. Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides. Am J Cardiol 2008;101:3-8. (Pubitemid 351173927)
16. Burnett JC Jr, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984;247:F863-6.
17. Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993;76:91-96 (Pubitemid 23027559)
18. Scriven TA, Burnett JC Jr. Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure. Circulation 1985;72:892-897 (Pubitemid 16245201)
19. Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998;4:37-44. (Pubitemid 28252539)
20. Redfield MM, Edwards BS, Heublein DM, et al. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure. Am J Physiol 1989;257:R917-23.
21. Showalter CJ, Zimmerman RS, Schwab TR, et al. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol 1988;254:R453-6.
22. Stevens TL, Burnett JC Jr, Kinoshita M, et al. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest 1995;95:1101-1108
23. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994;343:440-444 (Pubitemid 24059585)
24. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001;141:367-374 (Pubitemid 32200264)
25. Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-279 (Pubitemid 32885622)
26. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601. (Pubitemid 34123434)
27. Fonarow GC, Peacock WF, Phillips CO, et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007;49:1943-1950 (Pubitemid 46694287)
28. Doust JA, Pietrzak E, Dobson A, et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625. (Pubitemid 40444756)
29. Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001;76:1111-1119 (Pubitemid 33032388)
30. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003;41:571-579 (Pubitemid 36278374)
31. Mueller C, Laule-Kilian K, Scholer A, et al. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison. Kidney Int 2005;67:278-284 (Pubitemid 40019250)
32. Takami Y, Horio T, Iwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 2004;44:420-428 (Pubitemid 39164618)
33. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167 (Pubitemid 34764819)
34. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005;46:838-844 (Pubitemid 41224808)
35. Lang CC, Choy AM, Henderson IS, et al. Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin Sci (Lond) 1992;82:127-131
36. Kohse KP, Feifel K, Mayer-Wehrstein R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 1993;40:83-90. (Pubitemid 23244627)
37. Haug C, Metzele A, Steffgen J, et al. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Horm Metab Res 1994;26:246-249 (Pubitemid 24162471)
38. Safley DM, Awad A, Sullivan RA, et al. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis 2005;12:117-124 (Pubitemid 40255613)
39. Nakatani T, Naganuma T, Masuda C, et al. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med 2002;10:457-461
40. Brezis M, Rosen S, Silva P, et al. Renal ischemia: a new perspective. Kidney Int 1984;26:375-383 (Pubitemid 15224578)
41. Corboy JC, Walker RJ, Simmonds MB, et al. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Clin Sci (Lond) 1994;87:679-684 (Pubitemid 24373998)
42. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med 2005;53:366-370 (Pubitemid 41814250)
43. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-1515 (Pubitemid 32666334)
44. Goto T, Takase H, Toriyama T, et al. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 2002;92:610-615
45. Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001;59:1559-1566 (Pubitemid 32281248)
46. Pemberton CJ, Johnson ML, Yandle TG, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000;36:355-359 (Pubitemid 30694788)
47. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006;47:91-97 (Pubitemid 43005170)
48. Kistorp C, Raymond I, Pedersen F, et al. N-terminal pro-brain natriuretic peptide, Creactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005;293:1609-1616